Clinical Trials on C3 Glomerulopathy (C3G)
Total 78 results
-
ChemoCentryxMedpace, Inc.CompletedC3 Glomerulopathy (C3G)United States, Spain, France, Netherlands, Belgium, Canada, Denmark, Germany, Ireland, Italy, United Kingdom
-
NovelMed TherapeuticsNot yet recruitingC3 Glomerulopathy
-
Apellis Pharmaceuticals, Inc.Active, not recruitingC3G | IC-MPGN | C3 Glomerulopathy | C3 Glomerulonephritis | Complement 3 Glomerulopathy | Complement 3 Glomerulopathy (C3G) | Complement 3 Glomerulonephritis | Dense Deposit Disease | DDD | Membranoproliferative Glomerulonephritis | Membranoproliferative Glomerulonephritis (MPGN) | Immune Complex Membranoproliferative...United States, Spain, France, Germany, United Kingdom, Netherlands, Brazil, Israel, Japan, Australia, Austria, Italy, Switzerland, Korea, Republic of, Czechia, Belgium, Argentina, Canada, Poland
-
Apellis Pharmaceuticals, Inc.Active, not recruitingC3G | IC-MPGN | C3 Glomerulopathy | C3 Glomerulonephritis | Complement 3 Glomerulopathy | Complement 3 Glomerulopathy (C3G) | Complement 3 Glomerulonephritis | Dense Deposit Disease | DDD | Membranoproliferative Glomerulonephritis | Membranoproliferative Glomerulonephritis (MPGN) | Immune Complex Membranoproliferative...United States, Australia, Brazil, Czechia, France, Italy, Korea, Republic of, Netherlands, Spain, Switzerland, United Kingdom
-
Apellis Pharmaceuticals, Inc.AvailableC3G | IC-MPGN | C3 Glomerulopathy | C3 Glomerulonephritis | Complement 3 Glomerulopathy | Complement 3 Glomerulopathy (C3G) | Complement 3 Glomerulonephritis | Dense Deposit Disease | DDD | Membranoproliferative Glomerulonephritis | Membranoproliferative Glomerulonephritis (MPGN) | Immune Complex Membranoproliferative...United States
-
Apellis Pharmaceuticals, Inc.Active, not recruitingRenal Transplant | C3G | IC-MPGN | C3 Glomerulopathy | C3 Glomerulonephritis | Complement 3 Glomerulopathy | Complement 3 Glomerulopathy (C3G) | Complement 3 Glomerulonephritis | Membranoproliferative Glomerulonephritis | Membranoproliferative Glomerulonephritis (MPGN) | Immune Complex Membranoproliferative... and other conditionsUnited States, Australia, Austria, United Kingdom, Brazil, Argentina, France, Italy, Netherlands, Spain, Switzerland
-
Novartis PharmaceuticalsRecruitingC3 GlomerulopathySpain, France, Germany, Switzerland, United States, Japan, Turkey, China, United Kingdom, Italy, Argentina, Brazil, Greece, Israel, Netherlands
-
Alexion PharmaceuticalsCompletedC3 Glomerulopathy | C3 Glomerulonephritis | Dense Deposit DiseaseUnited Kingdom, United States
-
Mario Negri Institute for Pharmacological ResearchAlexion PharmaceuticalsCompletedIC-MPGN | C3 Glomerulopathy | C3 Glomerulonephritis | Dense Deposit Disease | Immune Complex Membranoproliferative GlomerulonephritisItaly
-
Region SkaneRecruitingC3 Glomerulopathy | C3 Glomerulonephritis | Dense Deposit Disease | Membranoproliferative Glomerulonephritis | Complement AbnormalitySweden
-
Alexion PharmaceuticalsAchillion, a wholly owned subsidiary of AlexionCompletedC3 Glomerulopathy | C3 Glomerulonephritis | Dense Deposit Disease | Immune Complex Mediated Membranoproliferative Glomerulonephritis | Membranoproliferative Glomerulonephritis Types I, II, and IIINetherlands, Australia, Belgium
-
AlexionTerminatedIC-MPGN | C3 Glomerulopathy | C3 Glomerulonephritis | Dense Deposit Disease | Immune Complex Membranoproliferative GlomerulonephritisUnited States, Australia, Belgium, Italy, Netherlands
-
Novartis PharmaceuticalsAvailableParoxysmal Nocturnal Hemoglobinuria (PNH) | C3 Glomerulopathy (C3G)
-
Omeros CorporationRecruitingC3 Glomerulopathy | Idiopathic Immune Complex-Mediated GlomerulonephritisLithuania, New Zealand, Poland, Tunisia, Turkey, United Kingdom
-
Arrowhead PharmaceuticalsRecruitingIgA Nephropathy | C3 GlomerulopathyNew Zealand, Australia, Korea, Republic of, Thailand, Germany, United Kingdom, Georgia
-
Pierre Fabre MedicamentEurotrials Brasil Consultores Cientificos LtdaWithdrawnVenous Disease Classification (CEAP): C2 or C3
-
Omeros CorporationUnknownLupus Nephritis | IgAN | C3 Glomerulopathy | MNUnited States, Hong Kong
-
AxioMed Spine CorporationUnknownSymptomatic Cervical Degenerative Disc Disease (DDD) From C3-C7Germany, Switzerland
-
Stanley Jordan, MDActive, not recruitingKidney Transplant Rejection | Kidney Transplant; Complications | Antibody-mediated Rejection | Transplant Glomerulopathy | Transplant Glomerulopathy - Late Form | Transplant Glomerulopathy - Early FormUnited States
-
University of Maryland, BaltimoreUniversity of Alabama at BirminghamTerminatedTransplant GlomerulopathyUnited States
-
Sohag UniversityRecruiting
-
Celldex TherapeuticsTerminatedC3 Glomerulonephritis | Dense Deposit Disease | Membranoproliferative Glomerulonephritis Type IIUnited States
-
Novartis PharmaceuticalsRecruitingC3GSpain, France, Switzerland, Germany, Greece, Turkey, Canada, India, United States, Czechia, Japan, Argentina, Brazil, Italy, Israel, United Kingdom, China, Belgium, Netherlands
-
Apellis Pharmaceuticals, Inc.Active, not recruitingLupus Nephritis | IgA Nephropathy | Membranous Nephropathy | C3 Glomerulonephritis | Dense Deposit DiseaseUnited States
-
Zhi-Hong Liu, M.D.Terminated
-
University of Illinois at ChicagoMallinckrodtTerminatedProteinuria | Transplant GlomerulopathyUnited States
-
Yale UniversityNational Institute on Drug Abuse (NIDA)Not yet recruiting
-
Sun Yat-sen UniversityRecruiting
-
Sun Yat-sen UniversityCompleted
-
Ohio State University Comprehensive Cancer CenterNational Heart, Lung, and Blood Institute (NHLBI); Food and Drug Administration...Recruiting
-
University of Massachusetts, WorcesterNational Institute on Drug Abuse (NIDA)Completed
-
Achieve Life SciencesCompletedVaping | E-Cig UseUnited States
-
Yale UniversityCompleted
-
Virginia Commonwealth UniversityRecruiting
-
Yale UniversityAmerican Heart AssociationRecruiting
-
University of VirginiaDuke UniversityRecruiting
-
Fundación Pública Andaluza para la Investigación...RecruitingObesity | GlomerulopathySpain
-
University of PittsburghUniversity of Pittsburgh Medical CenterTerminatedAdolescent Behavior | E-Cig UseUnited States
-
National Institute of Diabetes and Digestive and...Completed
-
University of PennsylvaniaNational Cancer Institute (NCI)Not yet recruitingSmoking | Tobacco Use | Cigarette Smoking | E-Cig Use
-
University Hospital, GrenobleClinical Investigation Centre for Innovative Technology Network; University... and other collaboratorsCompletedECG-PCG-CTG Acquisition on Pregnant Voluntary SubjectsFrance
-
University of PittsburghAmerican Heart AssociationRecruitingTobacco Use | Adolescent Behavior | E-Cig UseUnited States
-
University of PittsburghActive, not recruitingTobacco Use | Adolescent Behavior | E-Cig UseUnited States
-
BioCryst PharmaceuticalsTerminatedImmunoglobulin A Nephropathy | Membranous Nephropathy | Complement 3 GlomerulopathyFrance, Italy, Spain, United Kingdom
-
University of Southern CaliforniaCompletedElectronic Cigarette Use | Cigarette Smoking | Cigarette Use, Electronic | E-Cig UseUnited States
-
Virginia Commonwealth UniversityNational Institute on Drug Abuse (NIDA); Pennington Biomedical Research CenterCompletedFood Intake | Energy Intake | Appetite | E-Cig UseUnited States
-
Ohio State University Comprehensive Cancer CenterRecruiting
-
Glycomine, Inc.Recruiting24-Week Study to Assess the PD, Safety, Tolerability, and PK of GLM101 in Participants With PMM2-CDGPmm2-CDGSpain, Australia, United States
-
Centre Hospitalier Universitaire de NiceRecruitingExtramembranous GlomerulopathyFrance
-
National Institute of Diabetes and Digestive and...CompletedFocal Segmental Glomerulosclerosis | Glomerular Disease | Kidney Disease | Idiopathic Nephrotic Syndrome | Collapsing GlomerulopathyUnited States